Navigation Links
MAP Pharmaceuticals to Present Data From LEVADEX® Pharmacokinetics and Pharmacodynamics Safety Studies at the 63rd Annual Meeting of the American Academy of Neurology
Date:4/12/2011

c. to co-promote LEVADEX to neurologists and pain specialists in the U.S. MAP Pharmaceuticals also applies its proprietary drug particle and inhalation technologies to generate new pipeline opportunities by enhancing the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.  Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com

Forward-Looking Statements In addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to MAP Pharmaceuticals' LEVADEX product candidate.  Actual results may differ materially from current expectations based on risks and uncertainties affecting the company's business, including, without limitation, risks and uncertainties relating to the preparation and filing of a New Drug Application and the regulatory process to have the company's LEVADEX product candidate approved for commercial use.  The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release.  MAP Pharmaceuticals expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.  Additional information on potential factors that could affect MAP Pharmaceuticals' results and other risks and uncertainties are detailed in its Annual Report on Form 10-K for the year ended December 31, 2010, available at http://edgar.sec.gov. CONTACT:Nicole Foderaro

Lisa BorlandWCG

MAP Pharmaceuticals, Inc.(415) 946-1058

650-386-3122nfoderaro@wcgworld.com
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... -- British Journal of Urology International ... "male orgasmic dysfunction" with their doctor prior to any ... while preserving sexual function     ... paper in the British Journal of Urology International which ... with their doctors the likely impact of treatment options ...
(Date:10/31/2014)... -- Migranade, Inc. announced today the new migraine medication, ... million U.S. migraine sufferers November, 2014. The medicine is ... cause of migraines and not just the symptoms. While ... Migranade is assured to be a game changer in ... at http://www.migranade.com and will soon hit the ...
(Date:10/31/2014)... 31, 2014 Though therapies are in their ... to show an annual increase of 16.2% over the ... $1 billion, according to Kalorama Information,s report, Stem ... cell therapeutics that have gained or are expected to ... drug developers tackle ever more complicated conditions, stem cell ...
Breaking Medicine Technology:Sexual Dysfunction No Longer Inevitable When Treating Enlarged Prostate 2Game Changing Migraine Medication To Be Available November 2014 2Report: Stem Cell Technologies Market Growing 2
(Date:10/31/2014)... This Method to get a ... for practitioners. , The Hypopresive (aka Hipopressive) ... and Movement specializing in physical rehabilitation. Dr. Marcel ... reeducation that traditional abdominal exercises after pregnancy increased ... etc. , The Hipopressives exercises pull back in ...
(Date:10/31/2014)... Surgery for low back pain caused by spinal stenosis ... live, a new report says. "Nearly 80 percent ... point in their lives, and about 30 million people ... problem," co-author Brook Martin, of the Dartmouth Institute of ... news release. In spinal stenosis, thickening of tissue ...
(Date:10/31/2014)... say that either they or a family member have ... latest issue of The Gerontological Society of America,s ... which goes on to show that Americans strongly support ... end-of-life health care wishes. , This PP&AR , ... features 12 articles that present new ways of understanding ...
(Date:10/31/2014)... Miami Beach, Florida (PRWEB) October 31, 2014 ... Hydroponics” or, the “Company”) today announced it has signed ... three Canada-based companies in the urban cultivation sector - ... Ltd. (BC Northern Lights”), and W3 Metal Inc. (“W3 ... Lights, the “Target Companies”). Pursuant to the LOI ...
(Date:10/31/2014)... October 31, 2014 Triple Board Certified ... hair restoration services to transform the appearance of military ... American Academy of Facial Plastic and Reconstruction Surgery (AAFPRS) ... to restore the facial hair Jones lost during an ... The pro-bono hair restoration procedure, valued around $16,000, took ...
Breaking Medicine News(10 mins):Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 3Health News:Spinal Surgery Varies by Region in U.S.: Study 2Health News:Advance directives can benefit patients, families, and health care system 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 3Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 4Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 5Health News:Miami Hair Restoration Specialist Transforms Wounded Soldier 2
... 2011: In the context of rising levels of cardiovascular disease ... Cardiology (ESC) announces that for the first time- the Society ... Pacific Congress of Cardiology (APCC). The 18th edition of ... from 5 to 8 May 2011. The ESC deputation will ...
... for producing large quantities of a much-needed new imaging agent ... and other diseases, and the first evidence that the material ... tantalum oxide nanoparticle, which is inexpensive, and stays in the ... appears in the Journal of the American Chemical Society ...
... compound derived from tobacco, reduced plaques associated with dementia and ... a study led by researchers at Bay Pines VA Healthcare ... The findings are reported online in the Journal of ... found a compound that protects neurons, prevents the progression of ...
... research shows that high maternal viral load and co-infection ... factors associated with vertical transmission of the hepatitis C ... (CC) is associated independently with the spontaneous clearance of ... in the mother or children did not increase risk ...
... healthcare alliance for tobacco dependence treatment based at Mayo ... (IAHF) in Dallas, Texas, announced today the first of ... in Latin America on how to successfully treat tobacco ... several regional and global expert groups and scheduled for ...
... MEDFORD/SOMERVILLE, Mass. Colonoscopy is regarded as the ... but the potentially life-saving procedure can also be ... methods of screening to reduce patient discomfort while ... at Tufts University,s School of Engineering led by ...
Cached Medicine News:Health News:The European Society of Cardiology organizes educational program in Asia 2Health News:Tobacco-derived compound prevents memory loss in Alzheimer's disease mice 2Health News:Severity of hepatitis C and HIV co-infection in mothers contribute to HCV transmission to child 2Health News:Health care alliance for tobacco dependence treatment launches training in Mexico 2Health News:Health care alliance for tobacco dependence treatment launches training in Mexico 3Health News:A less painful colonoscopy 2Health News:A less painful colonoscopy 3
Multi-frequency, HST, linear transducer with a longer (60mm) footprint. Available with puncture adapter and water path. This transducer incorporates ALOKAs exclusive Hemispheric Sound Technology and ...
... Linear high frequency ... breast and superficial ... exclusive Hemispheric Sound ... technologies. This multi-frequency ...
... The UST-9121 is an excellent ... transducer with a wide scan ... this transducer is designed for ... intercostal window. The versatility of ...
... UST-9123 transducer is ALOKAs answer ... transducer.,This wide-band, Super High Density, ... is multi-frequency, offering 5 levels ... to 4 settings of Harmonic ...
Medicine Products: